Pain News and Research

Latest Pain News and Research

First Edition: Tuesday, July 1, 2014

Today's early morning highlights from the major news organizations, including numerous reports about the Supreme Court's decision on the health law's contraception mandate and its effect for coverage and on national politics.

1 Jul 2014

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.

From Baxter International Inc. 1 Jul 2014

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

1 Jul 2014

Pre-op assessment could improve post-op pain after arthroplasty

Spanish researchers have developed recommendations on how to assess and manage preoperative pain in patients undergoing total knee or total hip replacement.

30 Jun 2014

Tonsillectomy in adults improves quality of life

Tonsillectomy for recurrent pharyngitis in adults improves quality of life for the overwhelming majority of patients, report researchers.

30 Jun 2014

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.

30 Jun 2014

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

The omega-3 polyunsaturated fatty acids (PUFAs) found in seafood and marine oils called EPA and DHA may offer a simple, affordable way to reduce the effects of traumatic brain and spinal cord injuries by decreasing inflammation and nerve cell damage.

30 Jun 2014

Modified classification system finds over one-third of knee replacements as inappropriate

New research reports that more than one third of total knee replacements in the U.S. were classified as "inappropriate" using a patient classification system developed and validated in Spain. The study, published in Arthritis & Rheumatology, a journal of the American College of Rheumatology (ACR), highlights the need for consensus on patient selection criteria among U.S. medical professionals treating those with the potential need of knee replacement surgery.

30 Jun 2014

New concussion therapy program for NFL members

Upledger Institute Clinic in conjunction with the Ricky Williams Foundation announced today the launch of their concussion therapy pilot program aimed at treating current and former members of the NFL.

28 Jun 2014

Men advised to take proactive approach to prevent hernia

As the preeminent hernia specialist in the Western United States, Dr. Shirin Towfigh has diagnosed and treated a number of patients through incisional hernia surgery and other cutting-edge techniques.

28 Jun 2014

Wake Forest Baptist Physician offers tips to prevent bites and rashes in summer

When summer rolls around, nothing beats soaking up the rays, hiking in a forest or playing Frisbee with the family … until a mosquito, bee or poisonous plant ruins the fun.

28 Jun 2014

State highlights: N.C. lawmakers face off over Medicaid spending; heart surgery ratings in Ore.

North Carolina senators were not persuaded Thursday to accept Medicaid spending numbers for the coming year from Gov. Pat McCrory's administration after hearing a two-hour presentation led by State Budget Director Art Pope. Pope was summoned by the Senate Appropriations Committee to explain why McCrory's spending projection earmarks are much less than the Senate's to pay for unpaid claims from the year ending June 30 and additional enrollment and services for next year.

28 Jun 2014

Keele University researchers awarded grant to develop new treatment for musculoskeletal problems

Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.

28 Jun 2014

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.

28 Jun 2014

Non-surgical gum disease treatment reduces thickness of wall of arteries

A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.

28 Jun 2014

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

28 Jun 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

Alaska to be hit hard with hospital infection penalties

Elsewhere, medical marijuana's usefulness in treating pain is questioned after New York lawmakers legalized it.

27 Jun 2014

Research shows colon cancer survivors are more likely to experience pain in back, abdomen

Researchers from the University of Granada have discovered that colon cancer survivors are more likely to suffer future lesions related with pain in the back and lower abdomen than healthy individuals of the same gender and age.

27 Jun 2014

FDA clears ReWalk wearable robotic exoskeleton for home usage

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.

27 Jun 2014

Pain News and Research

Latest Pain News and Research

First Edition: Tuesday, July 1, 2014

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Pre-op assessment could improve post-op pain after arthroplasty

Tonsillectomy in adults improves quality of life

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

Modified classification system finds over one-third of knee replacements as inappropriate

New concussion therapy program for NFL members

Men advised to take proactive approach to prevent hernia

Wake Forest Baptist Physician offers tips to prevent bites and rashes in summer

State highlights: N.C. lawmakers face off over Medicaid spending; heart surgery ratings in Ore.

Keele University researchers awarded grant to develop new treatment for musculoskeletal problems

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

Non-surgical gum disease treatment reduces thickness of wall of arteries

Vertex receives positive opinion from European CHMP for approval of KALYDECO for cystic fibrosis

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Alaska to be hit hard with hospital infection penalties

Research shows colon cancer survivors are more likely to experience pain in back, abdomen

FDA clears ReWalk wearable robotic exoskeleton for home usage

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in